Lumiracoxib 是一种新型选择性 COX-2 抑制剂，IC50 和 Ki 分别为 0.14 μM 和 0.06 μM，选择性是 COX-1 的 515 倍。第四阶段。

Member of the neurotrophin growth factor family that binds and activates TrkB and p75 neurotrophin receptors. Enhances the survival, growth and differentiation of neurons. BDNF expression is altered in neurodegenerative disorders such as Parkinson's and Alzheimer's disease.

Homoeriodictyol 7-O-β-D-glucoside 是来自 Viscum coloratum(Kom.)Nakai 的天然产物。 Homoeriodictyol 7-O-β-D-glucoside 是血小板激活因子 (PAF) 的拮抗剂。